top of page
Search
A meeting with the UK health Security Agency on #antimicrobial resistance (AMR) development from cystitis treatments
Colleagues Some good news: I had a meeting with the #UKHSA this week to present my root cause analysis on #AMR. I was met by insightful...

Scott Glickman
Jun 25, 20241 min read
The new UK anti-AMR strategy plan
Colleagues I’ve been wading through the UK #governments second 5-year anti-AMR action plan, “Confronting #AntimicrobialResistance 2024-20...

Scott Glickman
Jun 6, 20241 min read
Wise strategies in uro-oncology presented at EAU 24
The case for widening the #intravesical approach to #bladder diseases and disorders In the European Association of #Urology 2024...

Gabriel Korn
Jun 3, 20241 min read
Combatting catheter associated #UTI (#CAUTI) - Tomorrow’s opportunities.
On the day of the UK’s launch of its new #AMR 5-year plan, I offer this account as it is closely linked in attempting to reduce the...

Gabriel Korn
May 9, 20242 min read
Doctors with commercial interests.
I offer this “case report” and cautionary note to dedicated doctors with inventive minds. For many years in UK medicine, the most...

Scott Glickman
May 7, 20242 min read


Cystitis and AMR. A critical analysis in <300 words,
UroPharma produced #intravesical drug-delivery technology to bring, under licence, better cystitis (lower #UTI) treatments. For decades,...

Scott Glickman
Apr 24, 20241 min read
Starvation amidst plenty with #urologic anti-infectives
#Epithelia line tissue surfaces that the outside world can directly access, such as skin, sclera, mouth, gut, vagina, #bladder and...

Scott Glickman
Apr 9, 20241 min read
Success, dependence and demise or innovation
When we find a solution to a problem, naturally we look to the same approach for the next similar challenge. #Antibiotics changed the...

Scott Glickman
Apr 9, 20241 min read
Recurrent UTI
Recurrent #cystitis reportedly occurs in about 25% of women within months after a first episode, which far exceeds recurrences from other...

Gabriel Korn
Mar 20, 20241 min read


A conundrum of #catheter coatings and #CAUTI
The distal urethra is a residency for #bacteria, mostly commensals, but sometimes potential uropathogens move in. #Catheterisation...

Gabriel Korn
Feb 5, 20241 min read
Responsible antibiotic stewardship
By Prof. Scott Glickman If a drug treatment for #cystitis is approved by a patient safety regulatory agency, without evidence that it can...

Gabriel Korn
Jan 26, 20241 min read
More on #Cystitis and #AMR
Homeostatic mechanisms optimise our cellular chemistry. #antibiotics treatments are developed specifically to work in our narrow-band...

Gabriel Korn
Jan 23, 20242 min read
Cystitis and its treatment (by Prof. Glickman)
I ask you to start the new year with a fresh look at cystitis and its management. While all the following are true: • The bladder is a...

Gabriel Korn
Jan 8, 20241 min read
AMR issues from cystitis treatments
From our Chief Medical Director, Professor Scott Glickman: With people working on AMR from cystitis treatments, I would be grateful to...

Gabriel Korn
Jan 3, 20241 min read


Antimicrobial Resistance in the bladder.
From our CMO Professor Scott Glickman Colleagues: In medical and surgical services spanning primary through intensive care, we are dogged...

Gabriel Korn
Dec 4, 20232 min read
bottom of page